Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • A relaxin based nanoparticle treats liver fibrosis

NIPER Leukemia Project Recruitment | Biotech / Life Sciences & Bioinformatics Apply

Can gut microbiome cause Parkinson’s disease!

A relaxin based nanoparticle treats liver fibrosis
  • BiotechToday
  • World

A relaxin based nanoparticle treats liver fibrosis

bioxone January 29, 2021January 29, 2021

PRIYANKA CHAKRABORTY, AMITY UNIVERSITY, KOLKATA

Liver fibrosis is one of the leading causes of morbidity and mortality among human beings. The unavailability of proper antifibrotic therapy makes the disease more deadly and the patients more vulnerable. RLX ( peptide hormone human relaxin-2), acting through a G protein-coupled receptor relaxin peptide receptor 1 (RXFP1), promotes tissue rebuilding and is antifibrotic over most major organs. Therefore,  mice without RLX develop rigorous fibrotic diseases with old age, completely opposed by treatment with recombinant RLX.

Scientists have used lipid nano-particles coupled with aminoethyl anis-amide, a critical ligand for the sigma-1 receptor expressed on activated HSC (Hepatic stellate cells), resulting in a targeted increase in RLX levels and striking retardation of fibrosis backing chronic liver injury. Notably, scientists identified crucial immunomodulatory effects of  RLX, resulting in an increase of hepatic restorative macrophages and a marginal reduction in fibrosis. 

Macrophages and monocytes have long been called a key controller of hepatic fibrosis and represent a positive pharmacological target. Therefore, monocyte recruitment in patients with liver fibrosis may hinder matrix construction. Hence, a therapeutic approach aimed at instituting macrophage phenotype in situ to govern pro-fibrotic characters and enhance restorative properties is extremely attractive, although so far been elusive. 

The major challenges in converting pre-clinical data from sample models into tractable treatments are the lack of comparative analyses in relevant human models. This information is also of broader regard as there are many other positive development opportunities, for RLX-based therapeutics, beyond fibrosis, including acute kidney injury/hepatorenal syndrome, musculoskeletal conditions, and many more. Nevertheless, this study provides a new method to use the intrinsic tissue construction properties of RLX that have excited researchers ever since its discovery.

Also read:Tata to launch Moderna COVID-19 vaccine in India

Citation:Fallowfield, J.A., Ramachandran, P. A relaxin-based nanotherapy for liver fibrosis. Nat. Nanotechnol. (2021). https://doi.org/10.1038/s41565-020-00832-w

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged cirrhosis hormone liver fibrosis macrophages micro RNA Monocytes nanoparticle Peptides phenotype plastic cells Protein receptor toxicity transplantation

One thought on “A relaxin based nanoparticle treats liver fibrosis”

  1. Pingback: Can gut microbiome cause Parkinson’s disease! - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Can gut microbiome cause Parkinson’s disease!

bioxone January 30, 2021

Souradip Mallick, National Institute of Technology, Rourkela  Parkinson’s disease (PD) affects at a rapid rate almost doubled within one decade. PD is a progressive degenerative disease that mainly affects the brain, the peripheral nervous system, and the gastrointestinal tract, causing progressive movement disorders, gastrointestinal and autonomic dysfunction, sleep disorders, and cognitive impairment. There is no […]

gut microbiome

Related Post

  • BiotechToday
  • World

Clinical Chemistry Analyzer in Laboratory Setting

bioxone November 24, 2020November 24, 2020

Sagnik Nag, Amity University Kolkata On November 18, 2020, the Medica EasyRA benchtop clinical chemistry analyzer was distributed and serviced by Greensboro-based company, which provides healthcare officials and staff to keep a routine test on blood chemistries to include and check metabolic activity profiles, liver enzymes, proper kidney functioning glucose levels, and cardiovascular tests. These […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Zinc Sparks associated with Fertilization

bioxone July 19, 2021July 19, 2021

Shayan Ahmed, Jamia Millia Islamia, New Delhi During fertilization, mammalian eggs undergo significant changes in zinc concentration and localization. Half a decade back, researchers at Northwestern University discovered that when human ova are fertilised by sperm, they emit billions of zinc ions. This abrupt exocytosis of about 10 billion zinc ions is known as zinc sparks […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Great Divide Basin shows the presence of prehistoric mammals

BioTech Today August 21, 2021August 20, 2021

Monika Raman, PSG College of Technology, Coimbatore A rich mammalian faunal assemblage, including several ‘condylarth’ species, has been discovered in an early Paleocene (Puercan) location in Wyoming’s Great Divide Basin (GDB).  The Journal of Systematic Palaeontology, a peer-reviewed journal, reports the finding of three new species of ancient animals. They are from the birth of […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy